In s earch f or bioactive c ompounds, 88 f ungal isolat es w ere c ollect ed from t hree Eg yptian marine habitats . Crud e extrac ts of 17 m arine derived fungal is olat es out of t he 88 isol at es show ed v ariable activit y ag ainst som e human pathogenic bac terial strai ns ( S almonella enterica, Prot eus sp., Klebs eilla pneumonia, Staphyloc occ us aureus and Escherichi a coli ). The m ost pot ent fungal isol at e that s howed the highes t antimicrobial activit y w as molec ularl y identified as As per gillus welwetsic hiae.
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ARTI CLE CODE: 28.02.16 I NTRODUCTI ON:
Ther e are two maj or t yp es of biologically import ant environm ents in whic h the s alt f act or will i nt erac t wit h microbial populati ons , soil and water (Mansum a et al., 2001) . The oceans and seas c ov er 70% of the eart h's sur fac e and poss ess a wide di versit y of nat ural flor a and f auna. Among the 36 know n living phyl a, 34 ar e f ound in m arine envir onm ents with more than 0.3 million know n speci es of fl ora and f auna (Faulkner, 2001) .
New tr ends in drug discov er y from natural s ourc es emphasiz e on i nvestiga ti on of the m arine ecos ystem t o explore num erous complex and novel c hemic al entities. Thes e entities ar e t he s ource of new lead f or treatment of m any diseases s uc h as canc er, A IDS , i nflamm at or y condition, art hritis, malaria and large v ariet y of viral, bact erial and fungal diseases (N azar et al. , 2009) . Bec ause of t he highl y c hemical and physic al hars h c ondition i n marine environm ent, the organisms produc e a v ariet y of m olec ules wit h unique s truct ural feat ures and exhibit v arious biological ac tivities (Ravik umar et al., 2010) .
Marine f ungi are prolific r es ourc es of natural prod ucts ( Ebel, 2010; J ensen and Fenic al, 2002) . H ow ever , t he potenti al of marine fungi has onl y been inv estigat ed t o a limited extent. In t he last few dec ades , marine-deriv ed f ungi have b een rec ogniz ed as one of the m ost rec ent bar el y t apped s ourc es for new biol ogicall y activ e sec ondar y metab olites (J ens en and F enic al, 2002) including antitum or, antibac terial, antiviral, antifungal, anti -infl ammat or y and enz ym e inhibitor comp ounds. This is probabl y because mari ne f ungi hav e been explor ed t o a lesser ext ent t han t heir terrestrial count erparts, w hic h hav e been k nown for a long tim e as a ver y important source of biologically activ e and ec onomic ally import ant natural produc ts, suc h as t hose f or us e i n treatment of hum an diseases as well as other biotec hnologic al applications (T an and Z ou, 2001; Strobel , 2002) .
Aspergillus f ungi hav e rec eived the most of t he att ention am ong all the marinederived f ungi, w hich account ed f or 31% of the marine fung al origin. The m arine nat ural products have divers e c hemical struc tur es mainl y incl uding; pol yk etides , fatt y acids, sterols and terpenoides, 96% of whic h displayed bioac tivities s uch as c ytotoxicit y, antimicrobial activit y, antioxidant and insec ticidal ac tivit y (Z hao, 2016) .
B act erial resistanc e is spreading throughout t he w orld; especi all y in all healt h care ass ociated p athogens r evealing the steadily d ecreasing p ot enti at es of preval ent antibiotics (G ould, 2008) ; t hus, necessitating the discov er y of n ov el compounds, modification of alread y existing antimicrobial stock , be it from fungi, ac tinom yc etes or any natural r esourc es. Bec ause of huge expenditure on s ynthetic m olec ule wit h eff ectiv e antimicrobial properti es, nat ural products ar e still a wort h pr omise. Alt hough, more suc h organisms for t heir antimicrobial potential t o solv e t he problem of emerging strains of r esist ant microorganisms (K aur and Arora, 2015 .
The pot ential of marine fungi t o produc e a vast array of sec ondar y metabolit es t hat ar e gaining importance f or t heir biotechnol ogical as w ell as m edical and pharm ac eutic al applications has at tract ed our att enti on. Howev er, the aim of t his st ud y is t o highlight the occ urrenc e of loc al marine f ungal isol at es havi ng t he c hemical pot ential of bioactiv e metab olites with antimicrobial activit y.
M ATERI AL AND M ETHODS:
Marine f ungi are an ecol ogicall y rat her than physi ologicall y or t axonomicall y defi ned group of microorganisms (H yde et al ., 1998) .
Col l ecti on of w ater sam pl es:
W ater samples w ere c ollect ed fr om three diff erent sit es i n Eg ypt; R ed Sea (Sharm El-Sheikh), Mediterranean S ea (Al exandria) and Bi tter l akes ( Ismailia). Fr om eac h locati on, samples w ere coll ect ed in cl ean sanitiz ed bottl es at a depth of 1. 5 meter using LaMott e w at er sampler (m odel JT -1 c ode 1077). Thes e s amples w ere c ollec ted (during March and April, 2012) , tr ans ferred t o the laborat or y and st ored in refriger ator f or furt her anal ysis. I sol ati on of M ari ne Fungi :
Three differ ent cult ure m edia w ere used for is olati on of marine fungi; Sab our aud dextros e yeast extr act ag ar medium (Feng et al., 1990) , Cz apek-D ox ag ar medium (Thom and C hurc h, 1926) , and Yeas t extract m edium (Wickerham, 1951) .
Is olation media w ere prepar ed with sea wat er and supplement ed with chl oramphenic ol (250 mg/L) as antibact erial agent. T he agar plates were inoc ulat ed wit h w at er s amples (0.2 ml) and inc ubat ed f or t hree w eeks. The agar plat es w ere reg ularl y exami ned to v erif y the growing c olonies. Disti nct fungal col oni es on the is olati on media w ere then transf erred to new p lates f or f urt her purification. The single purifi ed col oni es w ere picked up and subcult ured on slants prep ared from t he sam e contents of the isol ati on m edia and maint ained for f urt her inv estigations (S amuel et al., 2011) . Assessm ent of Anti m i crobi al Activi ty of M ari ne Fungal I sol ates: P repar ati on of the aqueo us crud e extr act:
Eac h 50 ml of Cz apek -Dox brot h medium (pH 6. 5) i n Erlenm eyer flasks ( 250 ml) was inoc ulat ed with one plug of eac h fungal isol at e and inc ubat ed in s haking incubator at 150 rpm, at 28°C for 7 days (Zainuddin et al ., 2010) . T he f ung al m yc elia were harves ted by filtr ation thr oug h W hatman filter pap er N o. 1, the sup ernat ant w as t hen filtered t hrough two t ypes of Millipore S yri nge filters (0. 45 μm) and (0. 22 µm) to g et c ell free extract (Manim egalai et al. , 2013) . The sterilized c ell free filtr ate was used f or screening of antibact erial and antif ungal activities agains t the t es ted bacteri al and fungal pat hogens.
Antim i crobi al acti vi ty test:
Agar w ell diffusion m et hod w as us ed t o eval uate t he antimicrobial ac tivit y of the sterilized cell free f ungal extract s (Mat han et al., 2013) The st erilized f ung al aq ueous extracts (200 µl) were loaded in t he w ells punched in agar plat es seeded wi th differ ent diluti ons of spore s uspension (c onc entration eq uival ent t o standard McF arland 0. 5) of the diff erent test ed pat hogens. F or bact erial pat hog ens , nutrient agar plat es ( APH A, 1917) wer e seed ed with spor e s uspension (10 8 ) and incubated at 37°C f or 24hrs. Cz apek -Dox agar plates wer e s eed ed wit h sp ore susp ensi on of (10 4 ) of t he fungal pat hog ens and inc ubated for 7 days . Malt extrac t agar plat es wer e seed ed with spore s uspensi on of yeas t pathogens (10 6 ) and inc ubated f or 48 hrs. Fung al and yeas t plat es w ere inc ubat ed at 28°C.T he m ean diam et er of inhibition zones were m eas ured in millimeters and recorded (Powt hong et al., 2012) .
I denti fi cati on of the acti ve m ari ne fungal i sol ates:
Id entific ati on was d et ermined bas ed on their macrosc opic and microscopic morphol ogical c har act eristics using the univ ersal manual ( De H oog et al., 2000) . The identific ation of the mos t pot ent isolate w as confirmed usi ng t he m olecul ar t echniques. M ol ecul ar i denti fi cati on of the m ost potent i sol ate:
Molec ular identification was c arried out in Sigma C ompany. DN A extr acti on was m ade by using protoc ol of G ene Plant g enomic DN A purification kit (T herm o) # K 0 791. Then PCR was m ade b y using Maxima H ot St art PCR Mast er Mi x (T herm o) # K 0221: F orward primer IT S1: (5'-TCC GTA G GT G A A CCT GCG G -3') and revers e IT S 4: ( 5' -TCC TCC GCT T AT TGA T AT GC-3').
Initial denatur ation at 95°C for 10 minut es. Denatur ati on 95°C f or 30 sec onds. Annealing at 55°C f or 1 minut e. E xtension at 72°C f or 1 minut e. Final ext ensi on at 72°C f or 15 minut e. N umber of c ycl es, 35. The PCR was cl ean up t o the produc t using Gene J ET TM PCR purificati on Kit (Thermo) # K 0701. Finall y seq uenci ng to t he PCR product w as made i n GA TC C ompany using f orward and revers e primers, AB I 3730xl DN A Seq uencer. Czapek-dox brot h medium ( 100 ml) was inoc ulat ed with pl ugs of the mos t pot ent marine f ungal isol at e (No. 9) and incubated i n a shaki ng inc ubat or (150 rpm) at 25°C, for 7 days. Af ter inc ubati on days, fungal m yc elium was s epar at ed from c ultur e brot h by filtration through W hatm an N o.1 filt er pap er. F or extraction of antimicrobial met abolit es, the filtrate w as treated with eq ual vol umes of four different organic s olvents namel y hexane, chlor oform, dichl oromethane and et hyl acetate. T hen, shaki ng t he mi xt ure vigorousl y for 10 minut es in a s eparating f unnel. The miscible mixtur e w as all owed to st and f or 5 minut es and the solv ent p has e c ont aini ng the fungal antimicrobial m etab olites was c ollec ted in a fl ask and c onc entrated in a rotat or evap orat or at 30°C. T he obt ained residue w as dissolved in 2% dimet hy s ulfoxide (D MSO) and st ored at 4°C. Ass essm ent of antimicrobial activit y was c arried out using agar well diffusi on m et hod. In nutrient agar plates wit h 0. The activ e c omponents i n the et hyl acetate crud e extr act wer e separ at ed using silica gel t hin layer c hrom at ography prec oated aluminum sheets 60F 25 4 ( Merck). Tw o m obile phas es w ere used for extracti on; et hyl acetate: chl oroform (1:1) (v /v) and diet hyl et her: petrol eum et her ( 1:1) (v/ v). The cr ude extract w as spot ted at 1. 5cm fr om the b ott om of t he sheets and all owed t o dry, t hen develop ed in an ascending order f or an hour. The produc ed spots w ere located b y t heir fluor esc enc e on c hrom at ograms under U. V light and Rf (retardation f act or) val ues wer e determined (At alla et al. , 2011) . El uci dati on of structure of the anti mi crobi al acti ve m etabol i te vi a spectro scopi c an al ysi s:
It is difficult t o acc ess t he original compound of int erest pres ent in nat ural products whic h is us uall y a c omplex mi xtur e of s ever al compounds. Thr ee i mport ant tec hniques w ere undert ak en t o reac h the struct ure of antimicrobial m et abolite: GC -MS , IR and N MR spec trosc op y.
-Fouri er Tran sform I nfrar ed R esonance spectro scopy (FTI R):
The infr ared sp ectra w ere r ecorded using pot assi um bromide disks on FT IR Therm o Electr on Nicol et 7600 (US A) infr ared spectrom et er at the C entral labor ator y of Facul t y of sci ence, Ai n s hams universit y.
-Gas ch rom atography -m ass sp ectrom etry (GC-M S)
The m ass spectr a wer e rec orded on Aglient Tec hnol ogies GC -MS 5977A mass spectrom et er op erati ng at 70 ev at t he C entral laborat or y of F ac ult y of s cience, Ai n s hams The purified antimicrobial c ompound was ev aluat ed f or c yt ot oxicit y ag ai nst W I-38 cell line (human Lung Fibroblast norm al cell). The c ell line was obtai ned from VAC SER A Tissue C ultur e Unit . T est w as carried out at the R egional Cent er f or Mycol og y & Biot ec hnolog y, Al -Az har Univ ersit y.
The cells w ere propagat ed in Dulbecc o's modified E agle's m edium (D ME M) supplemented with 10% heat -inac tivat ed f et al bovine s erum , 1% L-glut amine, HE PE S buff er and 50µg/ml gent am ycin. All c ells wer e maint ained at 37ºC i n a humidified atmospher e with 5% C O2 and wer e subcult ured tw o times a w eek.
The cells w ere seeded in 96-well plat e at a c ell concentr ation of 1 × 10 4 c ells per well. T est ed extrac ts diss olved i n D MSO wer e added to t he w ells in triplicates wit h concentrations of 0, 15.60, 31. 25, 62. 50, 12.50, 250 , and 500 μg/mL for 48 hrs. The cytot oxic activit y was d et ermined using viability ass ay. The optical d ensi t y w as meas ured with t he microplate reader (SunRise, T ECAN, Inc, US A) to det ermine the number of viable c ells and the percent age of viability w as calc ulated as [ 1-(ODt/ ODc)] x 100% where ODt is t he m ean optical densit y of w ells treat ed with t he tested s ample and ODc is the mean optical densit y of untr eated cells. T he r elati on betw een survivi ng c ells and drug concentration is plott ed t o g et the survival c urv e aft er treatm ent wit h the specified comp ound ( Mosmann, 1983; G omha et al., 2015) .
Stati sti cal Resul ts:
Statistical anal ysis of experimental dat a was perf ormed using IB M SP SS 2011; t o detec t t he optimum conditions f or maxim um antibact erial activit y of t he m ost pot ent marine-deriv ed fungal is olate. The probabilit y of error (P val ue) at 0. 05 or less w as consid ered signific ant, w hile at 0. 01 and 0. 001 highl y signific ant.
RESULTS AND DI SCUSSI ON : I sol ati on of m ari ne fungi:
In this study, eighty-eight marine fungal isolates were collected from the three different isolation sites in Egypt; 42 isolate (48%) from Red Sea, 32 isolate (36%) from Bitter lakes and 14 isolate (16%) from Mediterranean Sea.
The distribution of marine fungal isolates collected from different sites in Egypt.
Dat a of t his st ud y revealed t hat the yi eld of t he c ollect ed s amples w as higher fr om Red sea than other sit es. N adeem et al. (2015) reported that , R ed s ea w as rec ognized as a rich source of microbial diversit y wit h unique metab olites with pharm aceutic al and medicinal import ance. Assessm ent of anti mi crobi al acti vi ty of the i sol ates:
All marine-deriv ed fungal isol at es in this st udy w ere subjected t o antimicrobial activit y test agai nst a group of pathogenic bacteria, m old and yeast. As s how n i n table 1, the crude extr acts of onl y sev enteen (19%) marine-derived f ung al isolates s howed activit y ag ainst t he t est ed bact erial pathogens. T his data c oi ncides wit h other literat ures (Zhang et al. , 2012 (Zhang et al. , & 2013 Qin et al., 2015) , w here it w as r eport ed t hat 38% -59% of t he test extract s from marine f ungi exhibited antibact erial or antifungal activities . Also, Suay et al. (2000) report ed that about 70% of fungal s trains w ere activ e agains t bacteria. Is olates number 9, 10 fr om (R ed s ea) and N o. 16 from (Bit ter lak es) s howed ac tivit y agains t m ost of t he t est ed bact erial pathogens, where t he diameter of i nhibition zones ranged from 13mm i n cas e of E . coli t o 24 mm i n cas e of S almonella enterica. Accordingl y, is olat e N o. 9 had b een s elec ted for f urther inv estigations as being t he mos t potent is olate wi th the highest antibact erial activit y (inhibition zones rang ed from 19 mm to 24 mm).
In this st ud y, antibact erial ac tivit y w as found t o be m ore eff ectiv e t ow ards Gramnegative bact eria than Gram -positiv e bac teria. et al. (1999), H öller et al. (2000), and S uay et al. (2000) w her e t hey reported t hat antibact erial activit y is mor e common t ow ards Gram -positiv e bac teria t han Gram-negativ e bac teri a. T hese differenc es i n susc eptibility tow ards antibiotic ally activ e sec ondar y m et abolic extracts hav e b een repeat ed l y attribut ed t o diff erences in c ell wall struct ure of Gr am -positive b act eria c ompared to Gram-negative b act eria. The c ell w alls of Gram-positive bact eria are l ess c omplex and lack the nat ural si ev e eff ect agains t l arge molec ules (H awk ey, 1998), whereas th e out er membrane and t he periplasmic sp ace t hat is present in Gr am -negativ e bact eria is t hought to provide an additional degree of protec tion agains t antibiotics t argeti ng the cell wall (Basile et al., 1998) . B y t hat f act, i n t his stud y, t he mari ne-derived fungal isol at es from thos e regions in Egypt are of great importanc e since t hey ar e mor e ac tive agains t Gram-negativ e bac teria.
Identification of the active marine fungal isolates:
The s event een marine-derived fungal isolat es w hich gav e v ariable activit y agains t the t est ed bact erial pat hog ens wer e identified traditionall y b y t heir macr osc opic and microscopic c har act eristics (Table 2) . W hile the identific ation of t he m ost pot ent f ungal isolat e (N o. 9) was c onfirmed using the molec ular t ec hniques. In the c ur rent st udy, out of t he 17 active is olat es 14 (82%) belong ed to genus As per gillus, tw o Penicillium species ( 11%) and one Cladosporium species (Table  2 ) . In acc ordanc e to our res ults , D as et al. (2009) reported t hat , As per gillus was the mos t dominant g enus r epresenti ng 33% foll owed b y Penicillium 13% of t he m arine f ung al isol at es collect ed in his st udy. Xu et al. (2015) in t heir stud y, rep orted t hat dominant genera of the 105 marine fungi wit h antibac terial and antifungal ac tivit y w ere speci es of t he genus Aspergillus ( 31 s train) and t he genus Penicillium (16 s trai n), and considered Aspergillus as one of t he dominant marine fungi and str ains related to t his genus producing more new antibact erial and antifungal comp ounds than any ot her genus . Also, they rep orted t hat, over 700 c ompounds in t ot al wer e purified from 105 fungal strai ns that c an produc e antimicrobial c ompounds and were i nves tigat ed f or t heir activities . Ther e are 285 c ompounds (approximat el y 40% of t he tot al) s howed antibac terial and antifungal ac ti vities and 116 (15% of the total) are new antibact erial and antif ungal compounds. As per gillus f ungi have r ec eived the mos t of att enti on am ong all marine derived f ungi, w hich account ed f or 31% of the marine fungal origin (Zhao et al., 2016) .
As show n in t he r esult s of table 2, members of As pergillus ni ger (group) wer e represent ed by 12 ( 82%) out of 14 m arine fungal isol at es bel onging t o As per gillus genus. As per gillus niger as an example of one of the species r elat ed t o As per gilllus niger (group) is one of th e bes t pharm ac eutic al friendl y organism t hat produc es a lot of industriall y important enz ym es as w ell as some other products. Rel at ed t o antimicrobial activit y, it s hows high potenc y i n producing antimicrobial c ompounds such as tens yuic acid, nigerazi ne B, t ensidol A and oc hratoxi n (Nielsen et al. , 2009 ). 
M ol ecul ar i denti fi cati on of the m ost potent i sol ate (No.9):
A sequence database search using the BLAST search program analysis of the National Center for Biotechnology Information (NCBI, http://www. ncbi. nlm.nih.gov/BLAST/) against various sequences was used to identify the phylogenetic similarities among the Aspergillus niger (group) isolates and the published DNA sequences in GenBank. The BLAST search demonstrated that this isolate was closely related to As pergillus welwit schi ae with sequence similarity of more than 98% to the ITS1-5.8S-ITS2 regions of the rRNA genes using ITS1 and ITS4 primers and this was sufficient to indicate that this isolate belongs to the same species (As per gillus welwi tschi ae) (Figs 1 & 2) . 
Opti mi zati on of cul ture condi ti ons of Aspergillu s welwit sch iae:
The yi eld of bioactive compounds can sometimes be s ubst antiall y incr eas ed by the optimization of physic al (temper at ure, s alinit y, pH and light) and chemical f act ors (media components, prec ursors, and inhibitors) f or the growt h of microbes (Mi ao et al ., 2006; Ritchie et al., 2009; J ain and P undir, 2011; Sudark odi et al. , 2012) .
Antimicrobial activit y was first t est ed in both st atic and shak en c onditions ( 150 rpm). The obt ained r esults indic at ed t hat , antimicrobial activit y of shak en c ultur e w as higher than st atic one. For t his reas on, experiments i n t his st ud y w ere c arried out i n shaken c ondition at 150 rpm. Sel ection of a s uitable m edium for antimicrobial produc tion is an important st ep; suc h a m edium w as a prer equisite f or f urther studies (S hukla et al., 2014) . Thr ee diff erent media namel y; Czap ek -Dox brot h, Gluc os e Pept one Yeast extr act brot h and P ot at o Dextrose brot h ( Murray et al. , 2007) wer e test ed.
The antimicrobial activit y w as ass essed aft er 7 days of inc ubation at 28°C.
In this st ud y, the antibac terial activit y of Aspergillus wel witsc hiae w as recorded onl y on Cz apek-D ox broth m edium and the highes t i nhibition z one (30 mm) w as obtai ned ag ainst Salm onella enterica (T able 3). This res ult indicated t he s uit ability of (Mathan et al., 2013 (Mathan et al., ). K aren et al. (2013 test ed the import ance of differ ent m edia typ es, i ncluding si x liquid and fiv e s olid media on the sec ondar y met abolit e production of t hr ee fungal strai ns in t heir drug -discovery screeni ng process. T hey found a s urprising result that t he am ount of extract produc ed in liquid cultur es was of ten so drastic all y sm aller t han thos e produced in solid m edia c ultur es. Als o, produc tion varied widel y betw een the t yp es of the test ed media, but gener ally, rice appeared to be consist entl y produci ng high q uantiti es of t he activ e metabolit es.
Effect of tem per atur e on the anti bacteri al acti vi ty of Asperg illu s welwit sch iae:
In t his s tud y, thr ee set s of fl as ks contai ning Cz apek -dox brot h (pH 6. 5, i n shaking condition 150 rpm, f or 7 d ays) wer e incubated at t hree diff erent temper at ures (25, 30, and 35°C) . O ne-w ay ANO VA of normal data was c arried out and as shown i n table 3, there w as a significanc e diff erence b etw een diameters of i nhibition zones by As per gillus welwi tschi ae agains t Salm onella ent erica, E . coli and Prot eus s p. and incubation temperatur es at 25°C, 30°C, and 35°C. B y Pos t-hoc test, it w as prov ed t hat t emper atur e 25°C was t he optimum t emperatur e w ith 0. 006 level of significanc e (P = 0.006).
Bhatt ac har yya and J ha (2011) r eported that inc ubation t emperat ure r anging fr om 25°C t o 35°C to be optimum for antimicrobial activit y of As pergillus s trai n. Suj a et al. 
Effect of pH on th e anti bacteri al acti vi ty of Aspergillu s welwit sch iae:
The initi al pH of Cz apek -Dox brot h media w as adjust ed at t hree diff erent pH values (pH 5, pH7 and pH 9) usi ng 1N NaOH and 1N HC L. Flasks w ere inc ubated under shaking c onditions ( 150rpm) for 7 days at 28°C (Smit ha and R osamm a, 2014). O ne-w ay ANO VA of normal data w as carried out and as show n i n t able 3, that there was a significanc e difference betw een diameters of i nhibition zones b y As per gillus wel witsc hiae agains t Salm onella enteric a (p = 0.001) and Prot eus sp. (p = 0. 003) and pH v alues ( 5, 7, and 9) and b y Pos t-hoc t est, it w as prov ed that pH 9 was t he optim um pH val ue ag ainst bot h Salm onella enteric a and Prot eus s p. T her e was no signific ance differ enc e b etw een diameters of i nhibition zones by As per gillus welwi tschi ae ag ains t E . c oli. (p = 0.270) under different pH v alue t est ed.
The pH of a c ult ure medium is us uall y not const ant thr oughout f ermentation and the changes that occ ur ar e highl y dep end ent on compositi on of t he m edium ( Shukla et al. , 2014) . T hongwai and K unopak arn (2007) point ed out that mos t of microorganisms can synt hesis antimicrobial comp ounds at pH ranging from 5. 5 to 8. 5. J ain and P undir (2011) report ed t hat maxim um bioactiv e metab olite prod uction i n t heir s tud y w as at pH 6. 0, also Mat han et al. (2013) r ecorded pH 5. 5 was optimum f or As pergillus terreus , thes e studies sugges t t he acidophilic c har act eristics of the active is olat es. Likewis e, optim um pH for the growt h and sec ondar y met abolit e production of F usarium s olani w as f ound t o be 6. 0 by Mer lin et al. (2013) . O n t he c ontrar y, i n the current st udy, t he highest antibact erial activit y w as observ ed when A. wel witsc hiae was grow n at pH 9 and inhibition z one reac hed 32mm ag ains t Salmonella enteric a (Table 3) . Inhibition z ones w ere signific antl y less w hen t he f ung us w as grown at neutral and acidic pH. Effect of agi tati on speed on th e anti bacteri al acti vi ty of Asperg illu s wel witschi ae:
In t his st ud y, i noc ulated fl asks wit h Czapek-Dox brot h m edium w ere inc ubat ed at 28°C for 7 days at thr ee diff erent rp m (100,150, and 200).
For agit ation speed; one-way AN OV A of norm al dat a was carried out and as s hown i n table 3, there w as a significanc e differenc e between diameters of inhibition zones b y Aspergillus wel witsc hiae agai nst E . c oli (p = 0. 029) and Prot eus sp. (p = 0. 045) and different agitation sp eeds (100, 150, and 200) and by Pos t-hoc t est , it w as proved that 150 rpm was the optimum agit ation speed agains t both E. c oli and Prot eus s p. N o signific ant difference w as obs erved b etween diam et ers of i nhibition z ones by As pergillus wel witsc hiae agains t Salm onella ent erica (p = 0. 100) under different agitati on speeds.
It has b een r ep ort ed pr evi ousl y t hat a str ai n of As per gill us f umi gat us pr od uc ed bioac tiv e m etab oli t es on gr owt h m edi um , mai ze and c omm er ci al anim al feed wi t h rot ar y s hak er at 150 rp m (W enehed et al. , 2003; Li u et al ., 2004) . T his r es ul t al s o corr ob or at ed wi t h t hos e m enti oned b y A t all a et al. Effect of i ncub ati on peri ods on th e anti bacteri al acti vi t y of Asperg illu s wel witschi ae:
Time duration req uired for growth and metab olite producti on b y diff erent fungi vari es significantl y. T hus , proper det ermination of specific i ncub ation r equirem ent is of high importanc e f or maxim um harv esting of the metab olite (Alberts, 1990) . Inocul at ed flas ks of Cz apek-D ox broth medium w ere inc ubated at 28°C f or different i nc ubation peri ods (3 days, 5 d ays, 7 days, 9 days, 11 days , and 13 days) in s haking c onditions at 150 rpm. Antibact erial activit y w as recorded ev er y tw o days f or eac h s et of flask s.
One-w ay ANO VA of normal dat a w as carried out and as shown in t able 3, t her e w as a signific ant diff erence betw een diam et ers of inhibition zones b y As pergillus wel witsc hiae agains t E. c oli, Salmonella enteric a and Prot eus s p. and diff erent inc ubati on periods and b y Pos t-hoc t est , it w as prov ed that 3 -days inc ubati on period w as t he optimum incubation period with 0. 001 level of significance ( P = 0.001).
As s hown in t able 3, t he produc tion of antibact erial metabolit e v aried signific antl y with i nc ubati on days . Maxim um antibact erial activit y w as r ecorded aft er t hree days of incubation w her e i nhibition zones reac hed 39 mm, 37mm, and 21 mm agai nst eac h of E . coli, S almonell a ent erica, and Prot eus sp., respectiv el y. A ntibac terial activit y decr eased graduall y b y incr easing t he inc ubati on period and no activit y was observed by t he 13t h d ay of the i ncub ation p eriod. K al yani et al. (2016) reported m aximum antibac terial met abolit e production by Aspergillus niger when grow n for 144 h (6 days). K aur and Arora (2015) reported the maxim um antibact erial ac tivit y on 5 th d ay of incubation of A spergillus t erreus which r emai ned m ore or l ess st able till 9 th day and t hen declined.
The c ult ure st arts goi ng in decline phas e whic h res ults in red uced bioactivi t y and that m ay b e due to accum ulation of som e inhibitor y/ toxic residues ag ainst s ecreted bioactiv e compounds . The time c ourse f or antimicrobial ag ent produc tion differs ac cording t o t he strai n and c ultivation conditions . For inst ance, the maxim um antimicrobial agent produc tion was ac hieved aft er 5 days of i ncub ation of Penicillium corylophil um (Silva et al., 2004) and 4 days of incubation of Cl ados porium sp . ( Miao and Qian, 2005) . Organic s olvents also play an important role in extracti on of bioactive nat ural produc ts in t he f orm of crud e c ompounds from brot h media (G out am et al. , 2014) . Am ong four test ed organic solv ents for extracti on of antibact erial m et abolites fr om As per gillus welwi tschi ae , et hyl acetate was t he onl y solvent w hich extr act ed antibact erial metab olite giving 29 mm diam et er z one of inhibition agains t Salm onella ent erica upon antimicrobial ac tivit y t est (Fig. 3) . N egativ e control (2%D MSO) s how ed no antibact erial activit y and positiv e control (chl oramphenic ol 10 µg ) s howed 57 mm diam et er z one of inhibition. T he s ame res ults from t he st udy of Lu et al . (2000) and Sun et al. (2011) hav e used et hyl ac et at e as a solv ent for extracti on, while J ain and Pundir (2011) f ound t hat chlor oform w as the bes t solv ent for extrac ting Aspergillus metabolit es. W hen the brow n col ored cr ude metab olite extract ed b y et hyl ac et at e w as spott ed on silica gel TLC s heets and exami ned under U .V light for p urificati on, the result s how ed that t he et hyl acet at e c ont ai ned two fl uor esc ent spot s under U .V light ; one band trav elled thr oug h silica gel sheet wit h an RF v alue of 0.82 and t he ot her rem ained at the bas eline (Fig. 4) . To identif y t he extr act ed activ e compounds i n the separ at ed organic layer, the FT IR sp ectrum of t he extr act ed met abolit e show ed the appear anc e of broad peak at (3500 -3000 cm -1 ) charac teristic f or OH of carboxylic acid, peaks at 3020, 2929, and 2855 cm -1 charact eristic f or sp 2 and sp 3 CH and p eak s c haract eristic for carbonyl groups at 1741, 1727 and 1645 cm -1 (Fig. 5) . The abov e dat a indicat ed that t here is a mi xt ure of acid and es ter. To separ at e the acid, the mixture w as dissolved in s odium carbonate s olution (50%) follow ed b y extr acti on b y et hyl ac et at e. The organic l ayer gave a pur e solid whic h w as separated and identi fied b y sp ectros copic data as (bis-2-(ethyl hexyl) phthalate). T he IR spectrum (Fig. 6) show ed peaks at 2955, 2929, 2852 cm -1 c har act eristic f or sp3 CH and peaks c haract eristic f or c arbonyl est er at 1731 cm -1 . T he assigned str uct ures wer e supported b y 1 H-N MR and mass spec tra. The 1 H-NMR sp ectra rev eal ed t he exis tenc e of triplet peak c orresponding t o 4 CH 3 groups at δ 0.81 -0.84 ppm, a m ultiplet signals f or 8CH2 at δ1.19-1. 70 ppm, a multiplet signals for 2CH at δ 3.70 -3. 75 ppm , a m ultiplet signals f or 2 -OCH2 at δ4. 01 -4.12 ppm and multiplet signals f or aromatic prot ons at δ7.65 -7. 69 ppm (Fig. 7) . The MS spec trum s howed the correc t mol ecul ar ion peak at 391 corresponding t o M+ 1, beside s om e of abund ant peaks. The c hemic al c har act erizati on of the separated acid aft er acidificati on of the aqueous layer was det ermined based on elem ent al anal ysis and t he MS spectr al dat a ( The chemical characterization of active fraction extracted from the marine fungus Phoma h erbarum VB7 was determined based on the GC-MS and spectral data as Mono (2ethylhexyl) phthalate (Bhimba et al., 2012) . Atalla et al. (2011) in his study on marinederived fungus Penicillium brevicompactum have suggested that the isolated compounds which had an antimicrobial effect may be (di "2-ethyl hexyl" phthalate) and fungisterol or one of its isomers. These extracted compounds from both studies resemble the c ompounds extracted from the marine-derived fungus Aspergillus welwitschiae in this study.
Upon testing the antibacterial activity of each of bis-2-(ethylhexyl) phthalate and (Mono (2-ethylhexyl) phthalate) separately by agar good diffusion method against Salmonella enterica, they didn't exert any antibacterial activity against the test pathogen unlike testing them in mixture (acid and ester together) which was active against Salmonella enterica confirming the synergistic antibacterial effect of the two components together. Evaluation of cytotoxicity against WI-38 cell line: Upon investigating cytotoxicity of extracted antibacterial metabolite (mixture of acid and ester) towards WI-38 cell line (human lung fibroblast normal cells), it was shown from the obtained data (Fig. 9 ) that there was a very weak inhibitory activity against human Lung Fibrob last normal cells detected under these experimental conditions suggesting the possibility of considering it as a safe compound for further steps as a pharmaceutical product. Fig. 9 . Relation between viable cells (%) and drug concentration (µg/ml) extracted from A. welwitschiae
CONCLUSI ON:
This c urrent st ud y s uggests As pergillus welwi tschi ae as a potenti al c andidat e off ering a bett er sc ope f or the produc tion, purification and is olati on of broad spec trum antibact erial compound (especiall y agai nst Gram negativ e bacteria). Thes e findings i n addition to thos e rep ort ed f or ot her ac tiv e is ol at es i n t hi s st ud y ( 16 i solat e) m ay f aci lit at e t he s c al e up and f urt her purific ation to asc ert ain the compound r esponsible f or antimicrobial activit y and pharm aceutic al applications.
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